Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Serine/threonine-protein kinase mTOR | ||
| Ligand | BDBM50320100 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_635345 (CHEMBL1119658) | ||
| IC50 | 2.5±n/a nM | ||
| Citation |  Zhang, N; Ayral-Kaloustian, S; Anderson, JT; Nguyen, T; Das, S; Venkatesan, AM; Brooijmans, N; Lucas, J; Yu, K; Hollander, I; Mallon, R 5-ureidobenzofuranone indoles as potent and efficacious inhibitors of PI3 kinase-alpha and mTOR for the treatment of breast cancer. Bioorg Med Chem Lett20:3526-9 (2010) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Serine/threonine-protein kinase mTOR | |||
| Name: | Serine/threonine-protein kinase mTOR | ||
| Synonyms: | FK506-binding protein 12-rapamycin complex-associated protein 1 | FKBP12-rapamycin complex-associated protein | FRAP | FRAP 1 (mTOR) | FRAP1 | FRAP2 | MTOR | MTOR_HUMAN | Mammalian Target of Rapamycin (mTOR) | P42345 | RAFT1 | RAPT1 | Rapamycin and FKBP12 target 1 | Rapamycin target protein | Serine/threonine-protein kinase (mTOR) | mTORC2 | ||
| Type: | Rapamycin target protein | ||
| Mol. Mass.: | 288917.12 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | P42345 | ||
| Residue: | 2549 | ||
| Sequence: |
| ||
| BDBM50320100 | |||
| n/a | |||
| Name | BDBM50320100 | ||
| Synonyms: | 1-(2-((7-fluoro-5-methoxy-2-(1,3,5-trimethyl-1H-pyrazol-4-yl)-1H-indol-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-(4-(morpholine-4-carbonyl)phenyl)urea | CHEMBL1082620 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C36H33FN6O6 | ||
| Mol. Mass. | 664.6822 | ||
| SMILES | COc1cc(F)c2[nH]c(c(\C=C3\Oc4ccc(NC(=O)Nc5ccc(cc5)C(=O)N5CCOCC5)cc4C3=O)c2c1)-c1c(C)nn(C)c1C |(-4.1,-10.42,;-4.1,-11.96,;-2.77,-12.73,;-2.77,-14.28,;-1.43,-15.05,;-1.43,-16.58,;-.1,-14.27,;1.37,-14.74,;2.27,-13.49,;1.37,-12.24,;1.96,-10.82,;1.2,-9.49,;1.82,-8.08,;.67,-7.06,;.67,-5.53,;-.65,-4.75,;-1.98,-5.53,;-3.32,-4.77,;-3.33,-3.22,;-2,-2.45,;-4.67,-2.46,;-4.68,-.93,;-3.35,-.16,;-3.36,1.37,;-4.7,2.13,;-6.02,1.35,;-6.01,-.18,;-4.71,3.67,;-3.39,4.45,;-6.04,4.42,;-6.05,5.96,;-7.38,6.72,;-8.71,5.95,;-8.7,4.41,;-7.36,3.65,;-1.98,-7.07,;-.65,-7.82,;-.33,-9.33,;-1.36,-10.48,;-.1,-12.73,;-1.44,-11.96,;3.81,-13.49,;4.72,-14.74,;4.24,-16.21,;6.18,-14.27,;6.18,-12.73,;7.43,-11.82,;4.71,-12.24,;4.24,-10.78,)| | ||
| Structure | 
| ||